BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 26720294)

  • 1. Most Adults Support Medicare Coverage for Weight Loss Drugs.
    Harris E
    JAMA; 2024 Feb; 331(5):385. PubMed ID: 38231487
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceutical advertising and Medicare Part D.
    Lakdawalla D; Sood N; Gu Q
    J Health Econ; 2013 Dec; 32(6):1356-67. PubMed ID: 24308884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM
    JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Related Medication Nonadherence and Cost-Saving Behaviors Among Patients With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM; Cioffi GA; De Moraes CG
    JAMA Ophthalmol; 2015 Sep; 133(9):985-96. PubMed ID: 26042393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare Part D update--lessons learned and unfinished business.
    Neuman P; Cubanski J
    N Engl J Med; 2009 Jul; 361(4):406-14. PubMed ID: 19625722
    [No Abstract]   [Full Text] [Related]  

  • 6. Association Between Prescription Drug Insurance and Health Care Utilization Among Medicare Beneficiaries.
    Alexander GC; Schiman C; Kaestner R
    Med Care Res Rev; 2018 Apr; 75(2):153-174. PubMed ID: 29148319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financing new drug development in ophthalmology.
    Novack GD
    J Glaucoma; 2000 Apr; 9(2):195-9. PubMed ID: 10782633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Medicare Part D on the Availability of Medical Treatment for Patients With Glaucoma.
    Skuta GL; Mattox CG; Stein JD
    JAMA Ophthalmol; 2016 Feb; 134(2):220-1. PubMed ID: 26720294
    [No Abstract]   [Full Text] [Related]  

  • 10. [Glaucoma therapy - current overview of data and information].
    Výborný P; Sičáková S; Dohnalová P; Feřtek M; Doležal T
    Cesk Slov Oftalmol; 2013 Aug; 69(3):118-26. PubMed ID: 24437959
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.